Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoniazid-resistant tuberculosis: a cause for concern?
Helen R. Stagg, Marc Lipman, Timothy D. McHugh, et al.
The International Journal of Tuberculosis and Lung Disease (2017) Vol. 21, Iss. 2, pp. 129-139
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Vaccines Against Antimicrobial Resistance
Roberto Rosini, Sonia Nicchi, Mariagrazia Pizza, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 104
Recent advances in the treatment of tuberculosis
Ilaria Motta, Martin J. Boeree, Dumitru Chesov, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 9, pp. 1107-1114
Open Access | Times Cited: 31
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
Denise Rossato Silva, Margareth Pretti Dalcolmo, Simon Tiberi, et al.
Jornal Brasileiro de Pneumologia (2018) Vol. 44, Iss. 2, pp. 153-160
Open Access | Times Cited: 61
Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment
Shaveta Ahalwat, Dinesh Chandra Bhatt, Surbhi Rohilla, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1108-1108
Open Access | Times Cited: 18
Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid
Maunank Shah, Sonia Paradis, Joshua Betz, et al.
Clinical Infectious Diseases (2019) Vol. 71, Iss. 5, pp. 1161-1167
Open Access | Times Cited: 46
Novel Approaches for the Treatment of Pulmonary Tuberculosis
Zhi Ming Tan, Gui Ping Lai, Manisha Pandey, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1196-1196
Open Access | Times Cited: 43
Multi-Drug Resistance Tuberculosis (MDR-TB) Challenges in India: A Review
Deepak Vishwakarma, Abhay Gaidhane, Sweta Sahu, et al.
Cureus (2023)
Open Access | Times Cited: 13
Treatment Outcomes And Key Factors Contributing to Unfavorable Outcomes Among Isoniazid-Resistant Pulmonary Tuberculosis Patients in Shanghai, China
Wenjing Xiao, Jing Chen, Lixin Rao, et al.
Journal of Global Antimicrobial Resistance (2025)
Open Access
Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples
Gayathri Ramasubban, Joy Sarojini Michael, Richa Gupta, et al.
Frontiers in Tuberculosis (2025) Vol. 3
Open Access
Direct detection from sputum for drug-resistant Mycobacterium tuberculosis using a CRISPR-Cas14a-based approach
Guohui Xiao, Houming Liu, Hui Xu, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
Tuberculous Meningitis in Children and Adults: New Insights for an Ancient Foe
Alyssa Mezochow, Kiran T. Thakur, Christopher Vinnard
Current Neurology and Neuroscience Reports (2017) Vol. 17, Iss. 11
Open Access | Times Cited: 47
Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014
Basel Karo, Anke Kohlenberg, Vahur Hollo, et al.
Eurosurveillance (2019) Vol. 24, Iss. 12
Open Access | Times Cited: 39
Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
Byung Woo Jhun, Won‐Jung Koh
Tuberculosis & respiratory diseases (2019) Vol. 83, Iss. 1, pp. 20-20
Open Access | Times Cited: 38
A duplex one-step recombinase aided PCR assay for the rapid and sensitive detection of the isoniazid resistance genes katG and inhA in Mycobacterium tuberculosis
Zhiqiang Han, Xichao Ou, Ruiqing Zhang, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Harnessing Autoxidation of Aldehydes: In Situ Iodoarene Catalyzed Synthesis of Substituted 1,3,4-Oxadiazole, in the Presence of Molecular Oxygen
Jyoti Chauhan, Mahesh Kumar Ravva, Subhabrata Sen
Organic Letters (2019) Vol. 21, Iss. 16, pp. 6562-6565
Closed Access | Times Cited: 28
What will it take to eliminate drug-resistant tuberculosis?
Emily A. Kendall, S. Sahu, Madhukar Pai, et al.
The International Journal of Tuberculosis and Lung Disease (2019) Vol. 23, Iss. 5, pp. 535-546
Open Access | Times Cited: 26
Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens
Emmanuel Rivière, Michael G. Whitfield, Jochem Nelen, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 10, pp. 1332-1337
Open Access | Times Cited: 24
Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi, Vietnam
Nguyen Thi Le Hang, Minako Hijikata, Shinji Maeda, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 24
High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India
Neil Saldanha, Kiran Runwal, Charulata Ghanekar, et al.
BMC Infectious Diseases (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 23
New Xpert MTB/XDR: added value and future in the field
Arnold Bainomugisa, Christopher Gilpin, Christopher Coulter, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 5, pp. 2003616-2003616
Closed Access | Times Cited: 22
Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity
Ebru Koçak Aslan, M. İhsan Han, Vagolu Siva Krishna, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1301-1301
Open Access | Times Cited: 13
Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine
Luke T. Daum, Olha Konstantynovska, Oleksii Solodiankin, et al.
Journal of Clinical Microbiology (2018) Vol. 56, Iss. 6
Open Access | Times Cited: 23
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance
Helen R. Stagg, Graham Bothamley, Jennifer Davidson, et al.
European Respiratory Journal (2019) Vol. 54, Iss. 4, pp. 1900982-1900982
Open Access | Times Cited: 20
Targeting Mycobacterium Tuberculosis Enoyl‐Acyl Carrier Protein Reductase Using Computational Tools for Identification of Potential Inhibitor and their Biological Activity
Jitendra Kuldeep, Sandeep Sharma, Tanuj Sharma, et al.
Molecular Informatics (2020) Vol. 40, Iss. 5
Closed Access | Times Cited: 19
Linking azoles to isoniazid via hydrazone bridge: Synthesis, crystal structure determination, antitubercular evaluation and computational studies
Ebru Koçak Aslan, Vagolu Siva Krishna, Sanja J. Armaković, et al.
Journal of Molecular Liquids (2022) Vol. 354, pp. 118873-118873
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top